Evidence map›Paper›PMID 42196457›Full record

ArticleInternational journal of molecular sciences2026

Reactivation of

Andrea Acosta-Dent, Enrique García-Villa, Sandra Cotino-Nájera, Solangy Lizcano-Meneses, Francisco Alejandro Lagunas-Rangel, Efraín Garrido-Guerrero, José Díaz-Chávez, Patricio Gariglio

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andrea Acosta-DentDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados (CINVESTAV-IPN), Av. IPN No. 2508, Gustavo A. Madero, Mexico City 07360, Mexico.
Enrique García-VillaDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados (CINVESTAV-IPN), Av. IPN No. 2508, Gustavo A. Madero, Mexico City 07360, Mexico.
Sandra Cotino-NájeraDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados (CINVESTAV-IPN), Av. IPN No. 2508, Gustavo A. Madero, Mexico City 07360, Mexico.
Solangy Lizcano-MenesesDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados (CINVESTAV-IPN), Av. IPN No. 2508, Gustavo A. Madero, Mexico City 07360, Mexico.ORCID 0009-0007-4546-5863
Francisco Alejandro Lagunas-RangelDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados (CINVESTAV-IPN), Av. IPN No. 2508, Gustavo A. Madero, Mexico City 07360, Mexico.
Efraín Garrido-GuerreroDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados (CINVESTAV-IPN), Av. IPN No. 2508, Gustavo A. Madero, Mexico City 07360, Mexico.
José Díaz-ChávezSubdirección de Investigación Básica, Instituto Nacional de Cancerología, Av. San Fernando No. 22, Sección XVI, Tlalpan, Mexico City 14080, Mexico.ORCID 0000-0001-9583-3790
Patricio GariglioDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados (CINVESTAV-IPN), Av. IPN No. 2508, Gustavo A. Madero, Mexico City 07360, Mexico.

Funding

Consejo Nacional de Ciencia y Tecnología, Mexico 236767
6 · The paper itself

Abstract

Cancer is the second leading cause of death worldwide. Mutations in the

Indexed as

ApoptosisCell ProliferationMutationResveratrolTumor Suppressor Protein p53Cell Line, TumorGene Expression Regulation, NeoplasticHumansSignal TransductionStilbenesResveratrolStilbenesTP53 protein, humanTumor Suppressor Protein p53cancerchemosensibilizationmutant p53reactivationresveratrol

Identifiers

PMID42196457
PMCPMC13207096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.